Charles Zhu
Stock Analyst at LifeSci Capital
(2.76)
# 1,891
Out of 4,876 analysts
25
Total ratings
54.55%
Success rate
20.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBIO Crescent Biopharma | Initiates: Outperform | $22 | $17.07 | +28.88% | 1 | Jun 18, 2025 | |
| RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | $1.39 | - | 1 | Dec 13, 2024 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $8 | $5.06 | +58.26% | 3 | Nov 7, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | $12 | $1.24 | +867.74% | 4 | Nov 7, 2023 | |
| MRUS Merus | Maintains: Buy | $46 → $48 | $52.67 | -8.87% | 6 | Aug 8, 2023 | |
| NUVL Nuvalent | Initiates: Buy | $56 | $79.42 | -29.49% | 1 | Jul 24, 2023 | |
| TARA Protara Therapeutics | Assumes: Buy | $22 | $2.87 | +666.55% | 1 | Jul 10, 2023 | |
| COGT Cogent Biosciences | Reiterates: Buy | $26 | $7.14 | +264.15% | 3 | Jun 13, 2023 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $32 | $21.45 | +49.18% | 3 | Mar 8, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $14 | $12.21 | +14.66% | 2 | May 5, 2022 |
Crescent Biopharma
Jun 18, 2025
Initiates: Outperform
Price Target: $22
Current: $17.07
Upside: +28.88%
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.39
Upside: -
Tango Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $18 → $8
Current: $5.06
Upside: +58.26%
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $1.24
Upside: +867.74%
Merus
Aug 8, 2023
Maintains: Buy
Price Target: $46 → $48
Current: $52.67
Upside: -8.87%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $79.42
Upside: -29.49%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $2.87
Upside: +666.55%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $7.14
Upside: +264.15%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $21.45
Upside: +49.18%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $12.21
Upside: +14.66%